Emerging biomarkers for risk stratification in cardiogenic shock: steps closer to precision?-Reference-Cited by-同舟云学术

Emerging biomarkers for risk stratification in cardiogenic shock: steps closer to precision?

Published:2022-09-27 Issue:10 Volume:11 Page:739-741
ISSN:2048-8726
Container-title:European Heart Journal. Acute Cardiovascular Care
language:en
Short-container-title:

Author:

Szekely Yishay¹²³^ORCID,Luk Adriana¹²,Lawler Patrick R¹²⁴^ORCID

Affiliation:

1. Peter Munk Cardiac Centre and Ted Rogers Centre for Heart Research, University Health Network , 585 University Ave, Toronto, ON M5G 2N2 , Canada

2. Division of Cardiology, Department of Medicine, University of Toronto , 6 Queen's Park Crescent West, Toronto, ON, M5S 3H2 , Canada

3. Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University , 6 Weizmann St, Tel Aviv, 6423906 , Israel

4. Interdepartmental Division of Critical Care Medicine, University of Toronto , 6 Queen's Park Crescent West, Toronto, ON, M5S 3H2 , Canada

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

https://academic.oup.com/ehjacc/article-pdf/11/10/739/46754151/zuac112.pdf

Reference28 articles.

1. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association;van Diepen;Circulation,2017

2. The range of cardiogenic shock survival by clinical stage: data from the critical care cardiology trials network registry;Lawler;Crit Care Med,2021

3. Advancing from a ‘hemodynamic model’ to a ‘mechanistic disease-modifying model’ of cardiogenic shock;Lawler;J Heart Lung Transplant,2018

4. Advances in the staging and phenotyping of cardiogenic shock: part 1 of 2;Jentzer;JACC Adv,2022

5. Machine learning approaches for phenotyping in cardiogenic shock and critical illness: part 2 of 2;Jentzer;JACC Adv,2022